Brief: Regulus Therapeutics Announces Update On Preclinical Studies In Amyotrophic Lateral Sclerosis In Collaboration With Researchers From Harvard's Brigham And Women's Hospital
20/06/2023 14:17
June 20 (Reuters) - Regulus Therapeutics Inc RGLS.O :
* REGULUS THERAPEUTICS ANNOUNCES UPDATE ON PRECLINICAL
STUDIES IN
AMYOTROPHIC LATERAL SCLEROSIS IN COLLABORATION WITH RESEARCHERS
FROM HARVARD'S BRIGHAM AND WOMEN'S HOSPITAL
* REGULUS THERAPEUTICS INC - PRELIMINARY DATA FOR IN VIVO
STUDIES
ARE EXPECTED IN SECOND HALF OF 2023
Source text for Eikon: ID:nPn29Sxvva
Further company coverage: RGLS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview